Nadeem Zain Ali, Zainab Aqsa, Rehman Armaghan Ur, Fida Ariba, Malik Maha, Malik Neha, Nadeem Saad, Asif Muhammad Hussnain Bin, Sheikh Nisa Kapoor, Shoaib Muhammad Hamza, Amjad Nouman, Nadeem Aimen, Nashwan Abdulqadir J, Nadeem Muhammad Ahmad, Sohail Amir Humza
Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan.
Department of Medicine, King Edward Medical University, Lahore, Pakistan.
World J Surg. 2025 Sep 19. doi: 10.1002/wjs.70105.
Erector spinae plane block (ESPB) is a new anesthetic technique, but its use in inguinal hernia repair remains a subject of debate. We aim to determine the efficacy and safety of ESPB in reducing postoperative pain in inguinal hernia repair in adults.
We searched MEDLINE, Science Direct, Embase, CENTRAL, ClinicalTrials.gov, and WHO ICTRP for all relevant randomized controlled trials (RCTs) using ESPB in inguinal hernia repair. Two reviewers independently screened the studies, with a third resolving disputes. Risk of bias was assessed using the Cochrane RoB 2 tool. Data were analyzed on R version 4.4.1, using risk ratios (RRs) for dichotomous and mean differences (MDs) for continuous outcomes with 95% confidence intervals (CIs).
Meta-analysis of 6 RCTs revealed no significant reduction in postoperative pain with ESPB at rest or with movement at any time point nor did it significantly lower 24-h opioid consumption. However, in subgroup analysis, ESPB reduced the pain at rest at 12 h in the intraoperative subgroup (p < 0.01) and the 24-h opioid consumption in the intraoperative and the laparoscopic subgroups (p = 0.02). ESPB did not differ significantly from control in time to first rescue analgesia and proportion of patients requiring rescue analgesia. ESPB was not associated with nausea, vomiting, or urinary retention. One study was at high risk of bias, one with some concern, and four at low risk.
ESPB reduces opioid consumption following laparoscopic inguinal hernia repair, but the pain reduction is not clinically significant and the efficacy in open repair is uncertain.
竖脊肌平面阻滞(ESPB)是一种新的麻醉技术,但其在腹股沟疝修补术中的应用仍存在争议。我们旨在确定ESPB在减轻成人腹股沟疝修补术后疼痛方面的有效性和安全性。
我们在MEDLINE、Science Direct、Embase、CENTRAL、ClinicalTrials.gov和WHO ICTRP中检索了所有使用ESPB进行腹股沟疝修补的相关随机对照试验(RCT)。两名 reviewers 独立筛选研究,由第三名 reviewer 解决争议。使用Cochrane RoB 2工具评估偏倚风险。在R版本4.4.1上进行数据分析,使用二分类变量的风险比(RRs)和连续结果的均值差(MDs)以及95%置信区间(CIs)。
对6项RCT的荟萃分析显示,ESPB在任何时间点的静息或活动时术后疼痛均无显著减轻,也未显著降低24小时阿片类药物消耗量。然而,在亚组分析中,ESPB在术中亚组的12小时静息时减轻了疼痛(p < 0.01),在术中及腹腔镜亚组中降低了24小时阿片类药物消耗量(p = 0.02)。ESPB在首次抢救镇痛时间和需要抢救镇痛的患者比例方面与对照组无显著差异。ESPB与恶心、呕吐或尿潴留无关。一项研究存在高偏倚风险,一项存在一些担忧,四项存在低偏倚风险。
ESPB可降低腹腔镜腹股沟疝修补术后的阿片类药物消耗量,但疼痛减轻在临床上不显著,其在开放修补中的疗效尚不确定。